pergolide has been researched along with Cognition Disorders in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Flory, JD; Goodman, M; Harvey, PD; Koenigsberg, HW; McClure, MM; New, A; Siever, LJ; Sprung, LJ; Triebwasser, J | 1 |
| Mori, N; Nakamura, K; Sekine, Y; Suzuki, K; Takebayashi, K; Takei, N; Toulopoulou, T; Tsuchiya, KJ | 1 |
| Foncke, EM; Goudriaan, AE; Schmand, B; Schuurman, PR; Smeding, HM; Speelman, JD | 1 |
| Thompson, C | 1 |
| Graham, JM; Grünewald, RA; Sagar, HJ | 1 |
| Barbanoj, M; Berthier, ML; Estévez-González, A; García-Sánchez, C; Gironell, A; Kulisevsky, J; Pascual-Sedano, B | 1 |
| McHale, DM; Sage, JI | 1 |
| Goldstein, M; Gopinathan, G; Hiesiger, E; Leibowitz, M; Lieberman, AN; Nelson, J; Walker, R | 1 |
2 trial(s) available for pergolide and Cognition Disorders
| Article | Year |
|---|---|
Pergolide treatment of cognitive deficits associated with schizotypal personality disorder: continued evidence of the importance of the dopamine system in the schizophrenia spectrum.
Topics: Adolescent; Adult; Brain; Cognition Disorders; Dopamine; Dopamine Agonists; Double-Blind Method; Executive Function; Female; Humans; Learning; Male; Memory; Middle Aged; Neuropsychological Tests; Pergolide; Placebos; Receptors, Dopamine D1; Receptors, Dopamine D2; Schizotypal Personality Disorder; Treatment Outcome; Young Adult | 2010 |
Chronic effects of dopaminergic replacement on cognitive function in Parkinson's disease: a two-year follow-up study of previously untreated patients.
Topics: Aged; Antiparkinson Agents; Cognition Disorders; Dopamine Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Frontal Lobe; Humans; Levodopa; Male; Middle Aged; Motor Skills; Neuropsychological Tests; Parkinson Disease; Pergolide | 2000 |
6 other study(ies) available for pergolide and Cognition Disorders
| Article | Year |
|---|---|
Effective adjunctive use of pergolide with quetiapine for cognitive impairment and negative symptoms in schizophrenia.
Topics: Adult; Cognition Disorders; Dibenzothiazepines; Drug Therapy, Combination; Humans; Male; Pergolide; Quetiapine Fumarate; Schizophrenia; Schizophrenic Psychology | 2005 |
Pathological gambling after bilateral subthalamic nucleus stimulation in Parkinson disease.
Topics: Antiparkinson Agents; Cognition Disorders; Deep Brain Stimulation; Gambling; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Subthalamic Nucleus; Time Factors | 2007 |
Anwesenheit: psychopathology and clinical associations.
Topics: Aged; Antiparkinson Agents; Cognition Disorders; Epilepsy, Temporal Lobe; Ergolines; Grief; Humans; Lisuride; Male; Middle Aged; Pergolide; Schizophrenic Psychology; Sleep Wake Disorders | 1982 |
Hallucinosis in idiopathic Parkinson's disease.
Topics: Aged; Bromocriptine; Cognition Disorders; Depressive Disorder; Dopamine Agonists; Female; Hallucinations; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Psychomotor Disorders; Retrospective Studies; Severity of Illness Index; Time Factors | 1997 |
Hallucinations and confusion after pergolide withdrawal.
Topics: Aged; Cognition Disorders; Confusion; Female; Hallucinations; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Substance Withdrawal Syndrome | 1988 |
The use of pergolide and lisuride, two experimental dopamine agonists, in patients with advanced Parkinson disease.
Topics: Adult; Aged; Alanine Transaminase; Antiparkinson Agents; Aspartate Aminotransferases; Cognition Disorders; Dopamine; Drug Evaluation; Ergolines; Female; Humans; Lisuride; Male; Middle Aged; Nausea; Neurologic Examination; Parkinson Disease; Pergolide; Vasculitis | 1985 |